OTC Products - Netherlands

Netherlands

The OTC Products market in Netherlands is projected to reach a revenue of €1,026.00m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 3.37%, resulting in a market volume of €1,211.00m by 2029.
In global comparison, China is expected to generate the highest revenue in the OTC Products market, with €68.74bn in 2024.
When considering the total population figures, per person revenues of €58.05 are generated in Netherlands in 2024.
The Netherlands has seen a surge in demand for OTC cannabis products following the legalization of recreational marijuana.

Key regions: Europe, Australia, United Kingdom, Germany, South Korea

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The OTC Products (Pharmacies) market in Netherlands has been experiencing significant growth in recent years.

Customer preferences: Customers in the Netherlands have shown a strong preference for over-the-counter (OTC) products, which can be purchased without a prescription from pharmacies. This preference is driven by several factors, including convenience, accessibility, and the desire for self-care. Many consumers in the Netherlands value the ability to quickly and easily obtain medications and healthcare products without having to visit a doctor or obtain a prescription. This has led to an increased demand for OTC products in pharmacies across the country.

Trends in the market: One of the key trends in the OTC Products (Pharmacies) market in the Netherlands is the increasing availability and variety of products. Pharmacies are expanding their product offerings to meet the growing demand from customers. This includes a wider range of medications, healthcare products, and wellness items. Additionally, pharmacies are investing in technology and online platforms to make it easier for customers to access and purchase OTC products. This trend is driven by the desire to provide customers with a seamless and convenient shopping experience. Another trend in the market is the growing focus on natural and alternative remedies. Customers in the Netherlands are increasingly seeking out OTC products that are made from natural ingredients and have fewer side effects. This trend is influenced by a growing interest in holistic health and wellness, as well as a desire to reduce reliance on traditional pharmaceuticals. Pharmacies are responding to this trend by expanding their selection of natural and alternative remedies, and providing customers with more information and guidance on these products.

Local special circumstances: The OTC Products (Pharmacies) market in the Netherlands is also influenced by local regulations and healthcare system. The Netherlands has a well-developed healthcare system that provides universal coverage and access to healthcare services. This means that many OTC products are not covered by insurance and customers are required to pay out-of-pocket. However, the high level of income and disposable income in the Netherlands allows customers to afford these products. Additionally, the Dutch government has implemented strict regulations on the sale and distribution of medications, ensuring that customers have access to safe and effective OTC products.

Underlying macroeconomic factors: The growth of the OTC Products (Pharmacies) market in the Netherlands is supported by several underlying macroeconomic factors. The Netherlands has a stable and prosperous economy, with high levels of disposable income and consumer spending. This enables customers to afford OTC products and drives demand in the market. Additionally, the aging population in the Netherlands is contributing to the growth of the market. As the population ages, there is an increased need for healthcare products and medications, which are often purchased over-the-counter. In conclusion, the OTC Products (Pharmacies) market in the Netherlands is experiencing significant growth due to customer preferences for convenience and accessibility, as well as trends towards natural and alternative remedies. The market is also influenced by local regulations and the well-developed healthcare system in the country. The underlying macroeconomic factors, such as a stable economy and aging population, further support the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.